Three NbCAR-T cells, one tandem form (a single CAR structure consisting of two distinct antigen recognition domains targeting two tumor antigens), and two distinct monospecific forms, were designed against HER2 and CD20 tumor antigens. The gene discussed is ERBB2; the disease is neoplasm.